RecruitingPhase 2NCT05201469
VIBRANT: VIB4920 for Active Lupus Nephritis
Studying Systemic lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Maria Dall'Era, M.D.University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center
- Intervention
- VIB4920(drug)
- Enrollment
- 74 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2027
Study locations (17)
- University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla, California, United States
- UCLA Medical Center: Division of Rheumatology, Los Angeles, California, United States
- of California, Irvine School of Medicine Division of Rheumatology, Orange, California, United States
- University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center, San Francisco, California, United States
- University of Colorado School of Medicine: Division of Rheumatology, Aurora, Colorado, United States
- Yale University School of Medicine: Section of Rheumatology, New Haven, Connecticut, United States
- University of Miami Miller School of Medicine: Nephrology & Hypertension Division, Miami, Florida, United States
- Emory University School of Medicine: Division of Rheumatology, Atlanta, Georgia, United States
- University of Chicago, Department of Medicine: Rheumatology, Chicago, Illinois, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Washington University School of Medicine in St. Louis: Division of Nephrology, St Louis, Missouri, United States
- Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset, New York, United States
- Hospital for Special Surgery, New York: Division of Rheumatology, New York, New York, United States
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York, New York, United States
- Penn State Health Milton S. Hershey Medical Center: Division of Rheumatology, Hershey, Pennsylvania, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05201469 on ClinicalTrials.govOther trials for Systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07107659Safety and Efficacy of ONT01 in LupusHospital for Special Surgery, New York
- RECRUITINGNANCT07558850Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNCT06948110Deciphering the Genetic Architecture of Autoimmune DiseasesNational Human Genome Research Institute (NHGRI)
- RECRUITINGPHASE2NCT07409181A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Boehringer Ingelheim
- RECRUITINGPHASE3NCT07332481A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseEMD Serono Research & Development Institute, Inc.
- RECRUITINGEARLY PHASE1NCT07526350MTS109 in Patients With Refractory Autoimmune DiseasesShanghai Changzheng Hospital
- RECRUITINGEARLY PHASE1NCT07490041Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic DiseasesThe Children's Hospital of Zhejiang University School of Medicine
- RECRUITINGNANCT07470151Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology